Medicine and disease know no borders; thus, it is crucial to have cross-border partnerships in healthcare. As world leaders, China and the United States have a mutual duty and responsibility to pursue collaborations that will fulfill the growing healthcare needs of our patients and ensure patient safety.
On September 7, 2017, Taiping Investment Holdings Company Ltd., the University of California, San Francisco (UCSF) Health, and Pier 88 Health, Inc. met in Beijing to discuss potential collaborations to develop centers of excellence, train medical staff and professionals, provide high-quality care for overseas patients, and develop other aspects of in-depth partnerships.
Taiping Investment Holdings Company believes that insurance and medicine are interconnected, and that international medical institutions can effectively work together to foster the growth of insurance and healthcare in conjunction with one another.
UCSF Health expressed its willingness to potentially collaborate with Taiping Investment Holdings Company and Pier 88 Health to jointly advance healthcare worldwide for the benefit of patient health and well-being.
Pier 88 Health believes that the collaboration between these three institutions will promote Sino-US medical exchanges and cooperation, accelerate developments for the Chinese medical system and its healthcare professionals, and improve international healthcare standards.
During the signing ceremony, all three parties signed a Letter of Intent outlining collaborations to assist with advisory services in the areas of reproductive health, orthopedics, cancer, and other specialties; international destination programs for patients needing complex care; medical research; professional training and education support for physicians and nurses; and academic medical exchanges between China and the US.
太平投资总经理吴松、副总经理王干，UCSF Health执行董事Harold Lilly、国际部主任Nida Shekhani，彼爱医疗首席执行官罗敏等出席签约会议。
The signing ceremony was attended by Mr. Song Wu, President of Taiping Investment Holdings Company; Mr. Gan Wang, Vice President of Taiping Investment Holdings Company; Mr. Harold Lilly, Executive Director of UCSF Health, Ms. Nida Shekhani, Director of International Services of UCSF Health; and Ms. Min Luo, Chief Executive Officer of Pier 88 Health.
作为UCSF Health的基石，美国加州大学旧金山分校医学中心在《美国新闻与世界报道》提供的“全美最佳医院”排名中位居前五，同时，UCSF贝尼奥夫儿童医院在九项儿童专科领域均跻身全美最佳。UCSF Health是美国加州大学旧金山分校的学术医疗中心，凭借其创新的疗法、先进的技术、健康护理专业人员与科学家间的紧密合作以及富有同情心的病人护理团队而备受认可，并因其生物医学研究及卓越的研究生教育闻名于世。UCSF是美国国立卫生研究院研究基金资助的最大的公立接受者，已将其科研发现转化为超过2000项医学创新。UCSF全美卓越的项目包含癌症、儿童健康、大脑和神经系统、器官移植、女性健康和行为健康。（具体请参阅www.ucsfhealth.org）
About UCSF Health
As the cornerstone of UCSF Health, UCSF Medical Center is ranked among the top five hospitals in the United States by U.S. News & World Report, and UCSF Benioff Children’s Hospitals rank among the nation’s best in nine pediatric specialties. Recognized for innovative treatments, advanced technology, collaboration among health care professionals and scientists, and a highly compassionate patient care team, UCSF Health serves as the academic medical center of University of California, San Francisco, which is world-renowned for its biomedical research and graduate-level education. UCSF is the largest public recipient of research funds from the National Institutes of Health and has translated its discoveries into more than 2,000 new medical innovations. UCSF’s nationally preeminent programs include cancer, children's health, the brain and nervous system, organ transplantation, women's health and behavioral health. Visit www.ucsfhealth.org.
美国彼爱医疗集团（Pier 88 Health, Inc.）是美国资深华人执业医师、医学院教授，医院管理专家，医疗信息化专家等跨界人才共同创建的国际医疗平台，总部位于加州硅谷。其使命包括为中国医疗机构和医护专业人员提供世界一流的中美医疗交流和培训项目，以及为中国患者提供精准前沿、流程简易、价格公道的国际医疗服务。彼爱医疗致力于搭建中美医疗交流合作的高端精准平台，加速中国医疗系统和医护人才与国际接轨。彼爱医疗推动的合作内容涵盖多个领域，包括医院管理、临床技术、临床科研、医师培训、住院医规培体系建立、国际会诊、科室建设等；交流形式包括美国专家中国巡讲研讨、中国医院管理层赴美考察培训、中国医护骨干赴美观摩研修、中美医疗领袖峰会等。
About Pier 88 Health
Pier 88 Health is headquartered in Silicon Valley and was founded by a group of Chinese-American physicians, hospital management experts, and health IT professionals. Pier 88 Health’s mission is to provide world-class Chinese and American medical exchanges, offer Chinese hospitals and doctors professional education and training opportunities from the US, and to offer Chinese patients easy and affordable access to quality healthcare in the US. Pier 88 health is committed to building a Sino-US medical exchange and partnership to accelerate the Chinese medical system, as well as medical personnel and international standards. Pier 88 Health’s collaborations cover a diverse scope, including hospital management, technology, clinical research, physician training, international consultation, department development, and more. Medical exchanges encompass inviting US hospital physicians and industry experts to visit China’s top hospitals for knowledge sharing, inviting China’s hospital experts to the US for hospital management training, leadership summits, clinical observerships, and research